CDH1 and gastric cancer: Of the 33.3% of IGs diagnosed with gastric cancer in our cohort, only 4.8% were found to be harboring mutation in the CDH1 gene, whereas this ratio was comparatively high in the case of CGs (55% diagnosed with gastric cancer, 30% carrying a mutation in the CDH1 gene).